Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02145403
What this trial is testing

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesRelapseGraft-Versus-Host Disease
University of Michigan Rogel Cancer Center 53
Large-scale testing (Phase 3)Study completedNCT00034645
What this trial is testing

Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

Who this might be right for
Mycoses
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Ended earlyNCT04118556
What this trial is testing

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

Who this might be right for
GVHD, Acute
Mats Remberger 12
Testing effectiveness (Phase 2)Study completedNCT03812705
What this trial is testing

Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 6
Large-scale testing (Phase 3)Looking for participantsNCT06705062
What this trial is testing

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Cell TransplantGraft Versus Host Disease
Shanghai Jiao Tong University School of Medicine 316
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Testing effectiveness (Phase 2)Study completedNCT01794299
What this trial is testing

Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 31
Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Large-scale testing (Phase 3)Active Not RecruitingNCT03057054
What this trial is testing

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmLeukemia+1 more
Children's Oncology Group 173
Testing effectiveness (Phase 2)Study completedNCT01379209
What this trial is testing

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Who this might be right for
Graft Versus Host Disease
Regimmune Corporation 68
Large-scale testing (Phase 3)Looking for participantsNCT03818334
What this trial is testing

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Bone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more
Hospital Israelita Albert Einstein 50
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT07319000
What this trial is testing

Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Hospital Universitario Dr. Jose E. Gonzalez 35
Not applicableStudy completedNCT04882605
What this trial is testing

KIR Sequencing and Typing for Allograft in Nancy

Who this might be right for
Stem Cell Transplant Complications
Central Hospital, Nancy, France 156
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Testing effectiveness (Phase 2)Study completedNCT00923845
What this trial is testing

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Who this might be right for
Renal Cell CarcinomaGraft-Versus-Host DiseaseEngraftment Syndrome
National Cancer Institute (NCI) 25
Not applicableStudy completedNCT07048730
What this trial is testing

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Who this might be right for
Acute Leukemia
University Hospital, Bordeaux 51
Testing effectiveness (Phase 2)WithdrawnNCT04961801
What this trial is testing

Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia

Who this might be right for
LymphomaLeukemia
Shin Mineishi
Next Page